QA: Clovis Oncology Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001466301_2020_Clovis_Oncology_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001466301, Clovis Oncology Inc

  xvar xval
0 AssetsCurrent 366,468,000
1 IntangibleAssetsNetIncludingGoodwill 125,994,000
2 PropertyPlantAndEquipmentNet 15,287,000
3 remainder_Assets 161,855,000
4 LiabilitiesCurrent 133,084,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 710,777,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 185,825,879
9 ResearchAndDevelopmentExpense 276,560,943
10 remainder_Expenses 38,906,439
11 remainder_Revenues 309,056,073
12 remainder_NetIncome -25,307,020
13 remainder_ComprehensiveNetIncome -411,648
  yvar yval
0 Assets 669,604,000
1 Liabilities 843,861,000
2 Expenses 501,293,261
3 Revenues 309,056,073
4 StockholdersEquity -174,257,000
5 NetIncome -217,544,208
6 ComprehensiveNetIncome -217,750,032
7 BaseVar 1,174,766,501
8 EconomicCapitalRatiobeforeLimitedLiability -0.790
9 EconomicCapitalRatio 1.34

Edgar->Model Mapping

Feature Distribution

Change over Time